The test includes 8 biochemical analyses: total, direct, and indirect bilirubin (protected from light), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), apolipoprotein A1, alpha-2-macroglobulin, and haptoglobin. Results are processed using the METAVIR system, which reflects fibrosis stages from F0 to F4, widely accepted worldwide.
FibroTest allows accurate determination of the presence and degree of liver fibrosis, which is important for predicting disease progression and selecting treatment. The test is especially useful for patients with chronic hepatitis, as it helps assess the risk of cirrhosis development and long-term mortality related to liver diseases.
FibroTest is a set of calculated tests based on a mathematical model (biopredictive program, France) for assessing the degree of liver fibrosis using biochemical indicators from venous blood.
Please note that the research method and reference values may vary depending on the equipment and test systems used.